In Vivo Pretargeted Imaging of HER2 and TAG-72 Expression Using the HaloTag Enzyme

James C. Knight, Michael Mosley, H. Tetsuo Uyeda, Mei Cong, Frank Fan, Stephen Faulkner, Bart Cornelissen

Open source

DOI
10.1021/acs.molpharmaceut.7b00172
Published
2017-05-15
Container
Molecular Pharmaceutics
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.7b00172,
  title = {In Vivo Pretargeted Imaging of HER2 and TAG-72 Expression
Using the HaloTag Enzyme},
  author = {James C. Knight and Michael Mosley and H. Tetsuo Uyeda and Mei Cong and Frank Fan and Stephen Faulkner and Bart Cornelissen},
  year = {2017},
  journal = {Molecular
Pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.7b00172},
  url = {https://doi.org/10.1021/acs.molpharmaceut.7b00172}
}

RIS

TY  - JOUR
TI  - In Vivo Pretargeted Imaging of HER2 and TAG-72 Expression
Using the HaloTag Enzyme
AU  - James C. Knight
AU  - Michael Mosley
AU  - H. Tetsuo Uyeda
AU  - Mei Cong
AU  - Frank Fan
AU  - Stephen Faulkner
AU  - Bart Cornelissen
PY  - 2017
JO  - Molecular
Pharmaceutics
DO  - 10.1021/acs.molpharmaceut.7b00172
UR  - https://doi.org/10.1021/acs.molpharmaceut.7b00172
ER  - 

APA

Knight, J. C., Mosley, M., Uyeda, H. T., Cong, M., Fan, F., Faulkner, S., & Cornelissen, B. (2017). In Vivo Pretargeted Imaging of HER2 and TAG-72 Expression Using the HaloTag Enzyme. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.7b00172

Source records